Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood|March 7, 2024
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemiaYves Chalandon, Philippe Rousselot, Sylvie Chevret, et al.
Leukemia|February 24, 2026
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemiaNicolas Lecornec, Florence Rabian, Marie-Emilie Dourthe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 StudyRathana Kim, Yves Chalandon, Philippe Rousselot, et al.
Blood|August 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL studyRathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Blood|May 13, 2026
Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST StudyNicolas Boissel, Françoise Huguet, Thibaut Tl Leguay, et al.
Nature Communications|December 15, 2021
Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemiaAfonso R M Almeida, João L Neto, Ana Cachucho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2024
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22<sup>+</sup> Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic LeukemiaPatrice Chevallier, Thibaut Leguay, Marc Delord, et al.
Science Translational Medicine|July 8, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemiaCamille Vaganay, Frank Ling, Lois M Kelly, et al.
Cell Stem Cell|February 3, 2023
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemiaMarie Sebert, Stéphanie Gachet, Thierry Leblanc, et al.
Pageof 3